Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Andreas Manseck"'
Autor:
Nina N Harke, Christian Wagner, Robert M Hermann, Boris A Hadaschik, Jan Philipp Radtke, Alev Altay-Langguth, Stefan Aufderklamm, Christian Bach, Martina Becker-Schiebe, Andreas Blana, Frank Bruns, Stephan Buse, Stephanie E Combs, Christina L Engels, Emad Ezzibdeh, Marcel Fiedler, Laura-Anna Fischer, Mahmoud Farzat, Alexander Frismann, Matthias M Heck, Christoph Henkenberens, Marie C Roesch, Christoph Käding, Gunther Klautke, Philipp Krausewitz, Markus A Kuczyk, Conrad Leitsmann, Sebastian Lettmaier, Samy Mahjoub, Andreas Manseck, Daniel Medenwald, Andreas Meyer, Oliver Micke, Rudolf Moritz, Marcel Ott, Inga Peters, Sasa Pokupic, Daniel Porres, Felix Preisser, Kathrin Reichel, Andreas Schneider, Christian Schwentner, Sergiu Scobioala, Michael Truss, Daniel Wegener, Felix Wezel, Kay Willborn, Jörn H Witt, Andrea Wittig, Michael Wittlinger, Hendrik A Wolff, Volker Zimmermanns, Hans Christiansen
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0269827 (2022)
IntroductionSince the beginning of the pandemic in 2020, COVID-19 has changed the medical landscape. International recommendations for localized prostate cancer (PCa) include deferred treatment and adjusted therapeutic routines.Materials and methodsT
Externí odkaz:
https://doaj.org/article/33a1002b0bbd4df0899d4533c42ece72
Autor:
Ingmar Wolff, Martin Burchardt, Christian Gilfrich, Julia Peter, Martin Baunacke, Christian Thomas, Johannes Huber, Rolf Gillitzer, Danijel Sikic, Christian Fiebig, Julie Steinestel, Paola Schifano, Niklas Löbig, Christian Bolenz, Florian A. Distler, Clemens Huettenbrink, Maximilian Janssen, David Schilling, Bara Barakat, Nina N. Harke, Christian Fuhrmann, Andreas Manseck, Robert Wagenhoffer, Ekkehard Geist, Lisa Blair, Jesco Pfitzenmaier, Bettina Reinhardt, Bernd Hoschke, Maximilian Burger, Johannes Bründl, Marco J. Schnabel, Matthias May
Publikováno v:
Cancers, Vol 14, Iss 21, p 5356 (2022)
Patient’s regret (PatR) concerning the choice of therapy represents a crucial endpoint for treatment evaluation after radical prostatectomy (RP) for prostate cancer (PCA). This study aims to compare PatR following robot-assisted (RARP) and open sur
Externí odkaz:
https://doaj.org/article/3fff2cbea38f4c64a94fa782e4f72f25
Autor:
Nina N Harke, Jan P Radtke, Boris A Hadaschik, Christian Bach, Frank P Berger, Andreas Blana, Hendrik Borgmann, Florian A Distler, Sebastian Edeling, Tobias Egner, Christina L Engels, Mahmoud Farzat, Alexander Haese, Rainer Hein, Markus A Kuczyk, Andreas Manseck, Rudolf Moritz, Michael Musch, Inga Peters, Sasa Pokupic, Bernardo Rocco, Andreas Schneider, André Schumann, Christian Schwentner, Chiara M Sighinolfi, Stephan Buse, Jens-Uwe Stolzenburg, Michael C Truß, Michael Waldner, Christian Wülfing, Volker Zimmermanns, Jörn H Witt, Christian Wagner
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0239027 (2020)
IntroductionAfter the outbreak of COVID-19 unprecedented changes in the healthcare systems worldwide were necessary resulting in a reduction of urological capacities with postponements of consultations and surgeries.Material and methodsAn email was s
Externí odkaz:
https://doaj.org/article/73df329d7e8b4a04ad46891085d1ffa4
Autor:
Michael Froehner, Hans-Juergen Gaertner, Andreas Manseck, Sven Oehlschlaeger, Manfred P. Wirth
Publikováno v:
Sarcoma, Vol 4, Iss 4, Pp 179-181 (2000)
Patient. A 65-year-old man was admitted with a large primary retroperitoneal tumor and an increased β-human chorionic gonadotropin (β-HCG) serum level. A germ cell tumor was suspected; however, a computed tomography-guided biopsy failed to enable
Externí odkaz:
https://doaj.org/article/fe0914a198af4eb5aad38b1ea114cfcc
Autor:
Andreas Manseck, Alexander Piotrowski, Marius Butea-Bocu, Susan Foller, Jochen Gleissner, Andreas Kahlmeyer, Heinrich Karstedt, Ruth Kirschner-Hermanns, Timo Liebald, Clemens Linné, Volker Moll, Ullrich Otto, Alexander Schorn, Joachim Stein, Arnold Wagner, Andreas Wiedemann
Publikováno v:
ProCare. 27:12-17
Autor:
Markus Eckstein, Michael Hölzel, Franziska Erlmeier, Wilko Weichert, Jürgen Gschwend, Arndt Hartmann, Manuel Ritter, Bernd Wullich, Andreas Manseck, Patrick Adam, Alexander Mustea, Constantin Schwab, Stefanie Zschäbitz, Mahmoud Abbas, Katrin Schlack, Jens Bedke, Steffen Rausch, Eva Erne, Christopher Darr, Viktor Grünwald, Oliver Hahn, Thomas Büttner, Glen Kristiansen, Marieta Toma, Dora Nagy, Thomas Horn, Ralph M. Wirtz, Kristina Schwamborn, Philipp Erben, Friedemann Zengerling, Christian Bolenz, Johannes Breyer, Danijel Sikic, Abdullah Alajati, Eduard Below, Julia Albrecht, Florian Roghmann, Jörg Ellinger, Damian J. Ralser, Niklas Klümper
Supplementary Table 2. Baseline characteristics of the multicenter EV cohort.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7d0ab2f5d7eeb984dfc43547e294f47
https://doi.org/10.1158/1078-0432.22488674
https://doi.org/10.1158/1078-0432.22488674
Autor:
Markus Eckstein, Michael Hölzel, Franziska Erlmeier, Wilko Weichert, Jürgen Gschwend, Arndt Hartmann, Manuel Ritter, Bernd Wullich, Andreas Manseck, Patrick Adam, Alexander Mustea, Constantin Schwab, Stefanie Zschäbitz, Mahmoud Abbas, Katrin Schlack, Jens Bedke, Steffen Rausch, Eva Erne, Christopher Darr, Viktor Grünwald, Oliver Hahn, Thomas Büttner, Glen Kristiansen, Marieta Toma, Dora Nagy, Thomas Horn, Ralph M. Wirtz, Kristina Schwamborn, Philipp Erben, Friedemann Zengerling, Christian Bolenz, Johannes Breyer, Danijel Sikic, Abdullah Alajati, Eduard Below, Julia Albrecht, Florian Roghmann, Jörg Ellinger, Damian J. Ralser, Niklas Klümper
Purpose:The antibody–drug conjugate enfortumab vedotin (EV) releases a cytotoxic agent into tumor cells via binding to the membrane receptor NECTIN-4. EV was recently approved for patients with metastatic urothelial carcinoma (mUC) without prior as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2b69fedd60fed021579896f6da6328
https://doi.org/10.1158/1078-0432.c.6532790.v1
https://doi.org/10.1158/1078-0432.c.6532790.v1
Autor:
Andreas Manseck, A. Piotrowski, M. C. Butea, S. Foller, J. Gleissner, A. Kahlmeyer, H. Karstedt, R. Kirschner-Hermanns, T. Liebald, C. Linné, V. Moll, U. Otto, A. Schorn, J. Stein, A. Wagner, A. Wiedemann
Publikováno v:
Der Urologe. 61:3-12
Autor:
Niklas Klümper, Damian J. Ralser, Jörg Ellinger, Florian Roghmann, Julia Albrecht, Eduard Below, Abdullah Alajati, Danijel Sikic, Johannes Breyer, Christian Bolenz, Friedemann Zengerling, Philipp Erben, Kristina Schwamborn, Ralph M. Wirtz, Thomas Horn, Dora Nagy, Marieta Toma, Glen Kristiansen, Thomas Büttner, Oliver Hahn, Viktor Grünwald, Christopher Darr, Eva Erne, Steffen Rausch, Jens Bedke, Katrin Schlack, Mahmoud Abbas, Stefanie Zschäbitz, Constantin Schwab, Alexander Mustea, Patrick Adam, Andreas Manseck, Bernd Wullich, Manuel Ritter, Arndt Hartmann, Jürgen Gschwend, Wilko Weichert, Franziska Erlmeier, Michael Hölzel, Markus Eckstein
Purpose: The antibody–drug conjugate enfortumab vedotin (EV) releases a cytotoxic agent into tumor cells via binding to the membrane receptor NECTIN-4. EV was recently approved for patients with metastatic urothelial carcinoma (mUC) without prior a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bbb9683282bf9ec93947d81eacad5db
https://www.ncbi.nlm.nih.gov/pubmed/36534531
https://www.ncbi.nlm.nih.gov/pubmed/36534531
Autor:
Andreas Manseck, Thomas Pollmächer
Publikováno v:
Die Urologie ISBN: 9783642411687
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19c0dbc7e90f5d1609c83b8354f3ec09
https://doi.org/10.1007/978-3-642-41168-7_282-1
https://doi.org/10.1007/978-3-642-41168-7_282-1